A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma by Shenglan Huang, Shenglan Huang, Cairong Dong, Jian Zhang, Jian Zhang, Shumin Fu, Shumin Fu, Yaqin Lv, Yaqin Lv, Jianbing Wu, Jianbing Wu

Get full text

PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib by Yongkang Xu, Shumin Fu, Kai Shang, Jiayu Zeng, Ye Mao

Get full text

hsa_circ_0008305 facilitates the malignant progression of hepatocellular carcinoma by regulating AKR1C3 expression and sponging miR-379-5p by Shenglan Huang, Kan Liu, Yongkan Xu, Hua Wang, Shumin Fu, Jianbing Wu

Get full text

Efficacy and safety of hepatic arterial infusion chemotherapy combined with programmed cell death protein-1 antibody and lenvatinib for advanced hepatocellular carcinoma by Yongkang Xu, Shumin Fu, Ye Mao, Shenglan Huang, Dan Li, Jianbing Wu

Get full text

<i>CKLF</i> as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma by Dan Li, Shenglan Huang, Chen Luo, Yongkang Xu, Shumin Fu, Kan Liu, Jianbing Wu

Get full text

The role of ubiquitination and deubiquitination in cancer lipid metabolism by Yongkang Xu, Jiayu Zeng, Shumin Fu, Kan Liu, Ye Mao, Si Tao, Jianbing Wu

Get full text

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma by Shumin Fu, Yongkang Xu, Ye Mao, Mengting He, Zhimeng Chen, Shenglan Huang, Dan Li, Yaqin Lv, Jianbing Wu

Get full text

USP11 promotes lipogenesis and tumorigenesis by regulating SREBF1 stability in hepatocellular carcinoma by Yongkang Xu, Jiayu Zeng, Kan Liu, Dan Li, Shenglan Huang, Shumin Fu, Mao Ye, Si Tao, Jianbing Wu

Get full text